Pharmascience Welcomes Canadian Ruling On Nitrosamines
Class Action Related To Presence Of NDMA In Ranitidine Dismissed
Executive Summary
Pharmascience was among the firms that were named in a class action lawsuit in Canada over the presence of nitrosamine NDMA in ranitidine. Now, the company has welcomed a summary judgement decision by the Supreme Court of British Columbia to dismiss the claims.